ACHV
Price
$3.17
Change
-$0.05 (-1.55%)
Updated
Feb 21 closing price
Capitalization
109.02M
18 days until earnings call
PLRX
Price
$3.08
Change
+$0.07 (+2.33%)
Updated
Feb 21 closing price
Capitalization
187.43M
9 days until earnings call
Ad is loading...

ACHV vs PLRX

Header iconACHV vs PLRX Comparison
Open Charts ACHV vs PLRXBanner chart's image
Achieve Life Sciences
Price$3.17
Change-$0.05 (-1.55%)
Volume$150.67K
Capitalization109.02M
Pliant Therapeutics
Price$3.08
Change+$0.07 (+2.33%)
Volume$2.09M
Capitalization187.43M
ACHV vs PLRX Comparison Chart
Loading...
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACHV vs. PLRX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACHV is a Hold and PLRX is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (ACHV: $3.17 vs. PLRX: $3.08)
Brand notoriety: ACHV and PLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACHV: 56% vs. PLRX: 109%
Market capitalization -- ACHV: $109.02M vs. PLRX: $187.43M
ACHV [@Biotechnology] is valued at $109.02M. PLRX’s [@Biotechnology] market capitalization is $187.43M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACHV’s FA Score shows that 0 FA rating(s) are green whilePLRX’s FA Score has 0 green FA rating(s).

  • ACHV’s FA Score: 0 green, 5 red.
  • PLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, ACHV is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACHV’s TA Score shows that 5 TA indicator(s) are bullish while PLRX’s TA Score has 4 bullish TA indicator(s).

  • ACHV’s TA Score: 5 bullish, 3 bearish.
  • PLRX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ACHV is a better buy in the short-term than PLRX.

Price Growth

ACHV (@Biotechnology) experienced а -7.31% price change this week, while PLRX (@Biotechnology) price change was +1.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

ACHV is expected to report earnings on May 08, 2025.

PLRX is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PLRX($187M) has a higher market cap than ACHV($109M). ACHV YTD gains are higher at: -9.943 vs. PLRX (-76.614). ACHV has higher annual earnings (EBITDA): -29.95M vs. PLRX (-197.04M). PLRX has more cash in the bank: 405M vs. ACHV (42.9M). ACHV has less debt than PLRX: ACHV (9.85M) vs PLRX (60.2M). ACHV (0) and PLRX (0) have equivalent revenues.
ACHVPLRXACHV / PLRX
Capitalization109M187M58%
EBITDA-29.95M-197.04M15%
Gain YTD-9.943-76.61413%
P/E RatioN/AN/A-
Revenue00-
Total Cash42.9M405M11%
Total Debt9.85M60.2M16%
FUNDAMENTALS RATINGS
ACHV: Fundamental Ratings
ACHV
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACHVPLRX
RSI
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 9 days ago
82%
Bullish Trend 2 days ago
76%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SCGLY7.94N/A
N/A
Societe Generale
VITFF0.35N/A
N/A
Victoria Gold Corp.
JPXGY10.27-0.20
-1.93%
Japan Exchange Group, Inc.
DBSDF34.16-1.18
-3.34%
DBS Group Holdings Ltd.
CNTMF0.06-0.01
-10.11%
FLUENT CORP

ACHV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACHV has been loosely correlated with AXSM. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ACHV jumps, then AXSM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHV
1D Price
Change %
ACHV100%
-1.55%
AXSM - ACHV
37%
Loosely correlated
+6.70%
PLRX - ACHV
36%
Loosely correlated
+2.33%
ABOS - ACHV
35%
Loosely correlated
+0.72%
CRNX - ACHV
32%
Poorly correlated
+1.63%
TSVT - ACHV
32%
Poorly correlated
-2.61%
More

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with ITRM. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then ITRM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
+2.33%
ITRM - PLRX
41%
Loosely correlated
N/A
SRRK - PLRX
41%
Loosely correlated
-3.70%
FHTX - PLRX
40%
Loosely correlated
-2.79%
CRGX - PLRX
37%
Loosely correlated
+2.17%
HLVX - PLRX
37%
Loosely correlated
-2.14%
More